Dexchlorpheniramine

DB13679InvestigationalSmall molecule

Dexchlorpheniramine is a chlorpheniramine enantiomer antihistamine indicated in the treatment of sunburns, insect bites, and allergic reactions of the skin. The salt form dexchlorpheniramine maleate as the active ingredient is available as a prescription drug indicated for adjunctive therapy for allergic and anaphylactic reactions.

Chemical structure of Dexchlorpheniramine
Mechanism
Curator reviewed · 1 reference
Formula / weight
C16H19ClN2 · 274.79 g/mol (avg)

Resolves to

Compound
UNII3Q9Q0B929NCAS25523-97-1ChEMBLCHEMBL1201353ChEBI4464PubChem33036KEGGC06946
Clinical / RWD
RxNorm22697ATCR06AB02ATCR06AB52
Structure
InChIKeySOYKEARSMXGVTM-HNNXBMFYSA-NSMILESCN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
Targets
P35367HRH1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
719Drug interactionsStructured to mechanism, not free text
Sign in
20Clinical trialsPhase, status and sponsor resolved per trial
Sign in
11Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
11Marketed productsAcross 5 countries and 9 labellers
Sign in
2ATC codesIncluding every combination product, plus 16 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dexchlorpheniramine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In